| First Author | Zhou F | Year | 2017 |
| Journal | EMBO J | Volume | 36 |
| Issue | 11 | Pages | 1623-1639 |
| PubMed ID | 28468752 | Mgi Jnum | J:243432 |
| Mgi Id | MGI:5908485 | Doi | 10.15252/embj.201695372 |
| Citation | Zhou F, et al. (2017) USP4 inhibits SMAD4 monoubiquitination and promotes activin and BMP signaling. EMBO J 36(11):1623-1639 |
| abstractText | SMAD4 is a common intracellular effector for TGF-beta family cytokines, but the mechanism by which its activity is dynamically regulated is unclear. We demonstrated that ubiquitin-specific protease (USP) 4 strongly induces activin/BMP signaling by removing the inhibitory monoubiquitination from SMAD4. This modification was triggered by the recruitment of the E3 ligase, SMURF2, to SMAD4 following ligand-induced regulatory (R)-SMAD-SMAD4 complex formation. Whereas the interaction of the negative regulator c-SKI inhibits SMAD4 monoubiquitination, the ligand stimulates the recruitment of SMURF2 to the c-SKI-SMAD2 complex and triggers c-SKI ubiquitination and degradation. Thus, SMURF2 has a role in termination and initiation of TGF-beta family signaling. An increase in monoubiquitinated SMAD4 in USP4-depleted mouse embryonic stem cells (mESCs) decreased both the BMP- and activin-induced changes in the embryonic stem cell fate. USP4 sustained SMAD4 activity during activin- and BMP-mediated morphogenic events in early zebrafish embryos. Moreover, zebrafish depleted of USP4 exhibited defective cell migration and slower coordinated cell movement known as epiboly, both of which could be rescued by SMAD4. Therefore, USP4 is a critical determinant of SMAD4 activity. |
